FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer
Clinical trial NCT01133990 · TERMINATED
Trial details
- NCT number
- NCT01133990
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-04
- Primary completion
- 2011-02-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.